Actions and Detail Panel
Innovation Forum Masterclass: How to Scale-up Your Company to the Unicorn S...
Thu 27 April 2017, 17:30 – 21:00 BST
Only a decimal fraction of all tech start-ups ever gets valuated at $1 billion before going public and can thus be termed ‘unicorns’. At that stage, these companies are assured of the attention of prominent venture capitalists and to draw resumes from top talent across the globe. What makes these companies so unique that investors are happy to invest many millions in them? Tonight, a range of speakers will share their experiences and insights into what it takes to scale up your business after the initial stages. Join us on Thursday 27th April to find out.
In an informal setting, the audience can gain advice on how to accelerate your company to the next stage from someone who has gone through it himself. In the second half of the night, a London-based investor will reveal the secrets on how to get an investor to back you in the stages of investment after your initial years.
Dr. Gordon Sanghera, co-founder and CEO of Oxford Nanopore Technologies, will share his story on how it took their university spin-out less than ten years to become a global leader in the field of next-generation sequencing and be valued at £1.6 billion. After dinner, Sarah Hardy (Investment manager at Archangels) will share insights in what a promiment angel syndicate like theirs looks out for when selecting potential investments out of hundreds of annual applications.
Both sessions will be compered by Toby Reid, managing director of BioCity Scotland, a serial entrepreneur with extensive experience in supporting businesses in a wide variety of sectors, across the UK.
We call for a small audience of entrepreneurs, academics and investors to join us in this interactive night. Tickets include drinks and a dinner buffet throughout the night and a conclusive networking reception.
This masterclass will follow a public seminar entitled 'Power in your pocket: entering the DNA information age' by Dr. Gordon Sanghera on 27th April at 4pm at the Institute for Genetics and Molecular Medicine.